Literature DB >> 24370712

Tetanus in Italy 2001-2010: a continuing threat in older adults.

Antonietta Filia1, Antonino Bella2, Christina von Hunolstein3, Antonella Pinto3, Giovanna Alfarone4, Silvia Declich2, Maria Cristina Rota2.   

Abstract

Despite being a completely preventable disease, tetanus cases continue to occur in Italy and notification and hospitalization rates have been reported to be higher with respect to European and other industrialized countries. We examined statutory notification, hospitalization, mortality and seroprevalence data to describe tetanus epidemiology in Italy from 2001 to 2010. A total of 594 tetanus cases were notified, with an average annual incidence of 1.0/1,000,000 population. Most cases were unvaccinated or incompletely vaccinated. Eighty percent of cases occurred in subjects aged >64 years and a higher proportion of females with respect to males were reported in this age group. The annual number of hospital admissions was 1.4-1.7 times greater than the number of notifications in the same year. The mean annual number of reported deaths was 21. Seroprevalence data show progressively higher susceptibility levels with increasing age. Over 50% of persons aged 45-64 years and over two thirds of subjects ≥65 years had tetanus antibody levels <0.01 IU/ml. Results show that tetanus is a continuing problem in Italy and, as in other countries, most cases occur in older adults, especially elderly women. The observed differences in notification and hospitalization rates suggest underreporting by physicians. In recent years, Italy has accounted for most cases reported annually in the European Union (EU) but different case definitions are used. In Italy, a confirmed case is one that meets the clinical case definition while the EU case definition classifies confirmed cases as those with laboratory confirmation of disease. The incidence of clinical tetanus in Italy is ten-fold higher than in other industrialized countries, like Australia and Canada, likely due to higher susceptibility levels in Italy. In view of the low prevalence of tetanus antibodies in adults ≥45 years, strategies to improve vaccine uptake in this population group need to be implemented.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adults; Epidemiology; Hospital admissions; Immunity; Mortality; Tetanus

Mesh:

Year:  2013        PMID: 24370712     DOI: 10.1016/j.vaccine.2013.12.012

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  28 in total

1.  Hexavalent vaccines: characteristics of available products and practical considerations from a panel of Italian experts.

Authors:  A Orsi; C Azzari; E Bozzola; G Chiamenti; G Chirico; S Esposito; F Francia; P Lopalco; R Prato; R Russo; A Villani; E Franco
Journal:  J Prev Med Hyg       Date:  2018-06-01

Review 2.  Adult vaccination against tetanus and diphtheria: the European perspective.

Authors:  B Weinberger
Journal:  Clin Exp Immunol       Date:  2016-07-12       Impact factor: 4.330

3.  Trismus, the first symptom in a challenging diagnosis of Tetanus.

Authors:  Lorenzo Giannini; Alberto Maccari; Valentina Chiesa; Maria Paola Canevini
Journal:  BMJ Case Rep       Date:  2016-02-11

4.  Difficulties in identifying the bacterial species from the genus Clostridium in a case of injury-related osteitis.

Authors:  Marta Kierzkowska; Piotr Pędzisz; Ireneusz Babiak; Jakub Janowicz; Mateusz Kulig; Anna Majewska; Anna Sawicka-Grzelak; Grażyna Młynarczyk
Journal:  Folia Microbiol (Praha)       Date:  2018-03-09       Impact factor: 2.099

5.  Tetanus and diphtheria immunity in refugees in Europe in 2015.

Authors:  Alexandra Jablonka; Georg M N Behrens; Marcus Stange; Christian Dopfer; Ulrike Grote; Gesine Hansen; Reinhold Ernst Schmidt; Christine Happle
Journal:  Infection       Date:  2016-08-19       Impact factor: 3.553

6.  Tetanus vaccination, antibody persistence and decennial booster: a serosurvey of university students and at-risk workers.

Authors:  M Borella-Venturini; C Frasson; F Paluan; D DE Nuzzo; G DI Masi; M Giraldo; F Chiara; A Trevisan
Journal:  Epidemiol Infect       Date:  2017-03-15       Impact factor: 4.434

7.  Meningitis, clinical presentation of tetanus.

Authors:  Anna Moniuszko; Agata Zajkowska; Ewa Tumiel; Krzysztof Rutkowski; Piotr Czupryna; Sławomir Pancewicz; Ryszard Rutkowski; Agnieszka Zdrodowska; Joanna Zajkowska
Journal:  Case Rep Infect Dis       Date:  2015-02-18

Review 8.  How sex and age affect immune responses, susceptibility to infections, and response to vaccination.

Authors:  Carmen Giefing-Kröll; Peter Berger; Günter Lepperdinger; Beatrix Grubeck-Loebenstein
Journal:  Aging Cell       Date:  2015-02-26       Impact factor: 9.304

Review 9.  Decennial diphtheria-tetanus adult boosters: are they really necessary?

Authors:  C Trucchi; G Zoppi
Journal:  J Prev Med Hyg       Date:  2015-06-10

10.  Determination of Tetanus Antibody Levels in Trauma Patients Referred To Shahid Beheshti Hospital in Kashan, Iran, 2014.

Authors:  Hasan Afzali; Mohammad Reza Sharif; Shamsaddin Mousavi
Journal:  Arch Trauma Res       Date:  2015-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.